Epidemiological, clinical, and laboratory features of patients infected with Elizabethkingia meningoseptica at a tertiary hospital in Hefei City, China

Yajuan Li, Tingting Liu, Cuixiao Shi, Bo Wang, Tingting Li, Ying Huang, Yuanhong Xu, Lin TangFrontiers in Public Health 2022 · DOI

TL;DR

This study investigates the clinical and laboratory features of Elizabethkingia meningoseptica infections in a Chinese tertiary hospital, revealing fever as the most common symptom and hepatic disease as a significant risk factor for mortality. The findings highlight anemia, hypoproteinemia, and low lymphocyte counts as key indicators of poor prognosis, and suggest cotrimoxazole, quinolones, and piperacillin-tazobactam as potential preferred treatments.

What Problem Does This Paper Address?

Elizabethkingia meningoseptica (formerly Chryseobacterium meningosepticum) is an opportunistic Gram-negative bacterium known for causing nosocomial infections, particularly in immunocompromised individuals and neonates. It's notorious for its intrinsic resistance to many common antibiotics, making infections difficult to treat and leading to high mortality rates. While its presence in hospitals and association with severe outcomes are recognized, detailed epidemiological and clinical data from specific geographic regions, like Hefei City, China, have been limited. This study aims to fill this gap by providing a comprehensive analysis of E. meningoseptica infections in a tertiary hospital in Hefei, offering insights into patient characteristics, clinical presentations, laboratory findings, and factors influencing outcomes.

Methods

This was a retrospective analysis of 24 patients diagnosed with E. meningoseptica infection at the First Affiliated Hospital of Anhui Medical University between May 2017 and November 2021. Cases were identified by isolating E. meningoseptica from typically sterile sites (sputum or blood) and confirmed using MALDI-TOF MS. Patients were categorized into "survival" and "death" groups based on their outcome upon hospital discharge. Data collected included demographic information, laboratory results, clinical symptoms, comorbidities, treatment history, and in-hospital outcomes, all extracted from electronic medical records. Statistical analysis involved using SPSS, with continuous variables analyzed using Student's t-test or Mann-Whitney U-test, and categorical variables using Fisher's exact test. A P-value of <0.05 was considered statistically significant.

Datasets

The study utilized retrospective data collected from the electronic medical records of 24 patients diagnosed with E. meningoseptica infection at the First Affiliated Hospital of Anhui Medical University. No new datasets were created or introduced.

Key Insights and Ideas

  • Hepatic Disease as a Major Red Flag: The study identified hepatic disease as the only significant underlying risk factor associated with a higher mortality rate (P=0.009). This suggests that patients with liver issues are particularly vulnerable to severe outcomes from E. meningoseptica infections.
  • Anemia and Hypoproteinemia as Prognostic Indicators: Beyond underlying conditions, laboratory findings like anemia and hypoproteinemia were significantly more prevalent in the death group, indicating their role as critical markers for predicting a poorer prognosis.
  • Lymphocyte Count as a Differentiator: Interestingly, a higher mean lymphocyte count was observed in the survival group compared to the death group, suggesting a potential role for immune response in patient outcomes.
  • Antibiotic Susceptibility Patterns: The study confirmed E. meningoseptica's resistance to many common antibiotics but highlighted a relatively high susceptibility to cotrimoxazole, quinolones, and piperacillin-tazobactam, offering valuable guidance for empirical treatment strategies.
  • Adult-Dominant Infections in Hefei: Unlike some previous studies that emphasized neonatal infections, this cohort predominantly consisted of adult patients, suggesting a potential shift or regional difference in the typical patient profile for E. meningoseptica in this area.

Key Results

  • Prevalence: A total of 24 patients were identified with E. meningoseptica infection.
  • Mortality Rate: The study reported a mortality rate of 41.6% (10 out of 24 patients died).
  • Common Symptoms: Fever was the most prevalent symptom (83.3%), followed by altered consciousness and edema (both 41.7%), and cough and sputum (both 37.5%).
  • Common Laboratory Findings: Anemia (75%) and hypoproteinemia (75%) were the most frequent laboratory abnormalities. Elevated C-reactive protein (CRP) (66.7%), neutrophilia (54.2%), and leukocytosis (50.0%) were also common.
  • Significant Risk Factors for Death: Anemia (P=0.024), hypoproteinemia (P=0.024), and lower lymphocyte counts (P=0.033) were significantly associated with a higher risk of death.
  • Antibiotic Susceptibility: E. meningoseptica showed high resistance to cefazolin (100%) and amikacin, aztreonam, imipenem, and tobramycin (95.8%). The most active antibiotics identified were cotrimoxazole (87.5%), levofloxacin (75.0%), and piperacillin/tazobactam (75.0%).

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Single-Center Study: This design means data may be incomplete or subject to reporting biases.
  • Limited Sample Size: The relatively small number of patients (N=24) restricts the generalizability of the findings to larger populations.
  • Lack of Data on Certain Antibiotics: Data on vancomycin and minocycline susceptibility were not available, limiting a complete picture of treatment options.

Future work could involve larger, multi-center prospective studies to validate these findings and explore the genetic basis of resistance and virulence factors in more detail. Continued monitoring of antibiotic susceptibility patterns is crucial for adapting treatment strategies. The authors also emphasize the need for strengthened hospital environmental disinfection and staff adherence to aseptic practices due to the bacterium's ability to form biofilms.

Summary updated

Abstract

Fever was the most common symptom and the only significant factor of underlying diseases was hepatic disease (<i>P</i> = 0.009) that often occurred in death groups. In this investigation, the risk factors for death in patients were anemia, hypoproteinemia, and lymphocyte count. The susceptibility of some quinolones, piperacillin-tazobactam, and cotrimoxazole was relatively high, suggesting that they may be the preferred drugs for the treatment of <i>E. meningoseptica</i> infection. As <i>E. meningoseptica</i> can produce biofilm to pollute the hospital environment and cause infection in patients, the disinfection of the hospital environment should be strengthened and medical staff should pay attention to aseptic operations.
BibTeX
@inproceedings{li2022epidemiological,
  author = {Yajuan Li and Tingting Liu and Cuixiao Shi and Bo Wang and Tingting Li and Ying Huang and Yuanhong Xu and Lin Tang},
  title = {{Epidemiological, clinical, and laboratory features of patients infected with Elizabethkingia meningoseptica at a tertiary hospital in Hefei City, China}},
  booktitle = {Frontiers in Public Health},
  year = {2022},
  doi = {10.3389/fpubh.2022.964046},
}
Figure